tru Independence’s AbbVie ABBV Stock Holding History

tru Independence’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$346K	Sell	1,589 -17,848	-92%	-$3.96M	0.17%	73
2025 Q4	$4.44M	Sell	19,437 -32	-0.2%	-$7.29K	1.12%	43
2025 Q3	$4.51M	Buy	19,469 +155	+0.8%	+$31.6K	1.17%	42
2025 Q2	$3.59M	Buy	19,314 +207	+1%	+$38.5K	1.04%	44
2025 Q1	$4M	Buy	19,107 +799	+4%	+$155K	1.24%	39
2024 Q4	$3.25M	Sell	18,308 -164	-0.9%	-$30.2K	1.02%	42
2024 Q3	$3.65M	Sell	18,472 -16,919	-48%	-$3.16M	1.07%	46
2024 Q2	$6.07M	Buy	+35,391	New	+$5.86M	1.83%	21
2021 Q1	–	Sell	-1,434	Closed	-$154	–	298
2020 Q4	$154	Buy	1,434 +139	+11%	+$13.4K	﹤0.01%	439
2020 Q3	$113K	Sell	1,295 -9,834	-88%	-$926K	0.03%	182
2020 Q2	$1.09K	Sell	11,129 -2,747	-20%	-$242K	0.16%	106
2020 Q1	$1.06K	Hold	13,876	–	–	0.17%	95
2019 Q4	$1.06M	Buy	+13,876	New	+$1.15M	0.15%	109

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

tru Independence's ABBV Position: Q1 2026 in Review

tru Independence reduced its AbbVie (ABBV) stake by 92% in Q1 2026, selling an estimated $3.96M and leaving 1,589 shares worth $346K. The position accounts for 0.17% of the portfolio, ranked #73.

tru Independence first reported a position in ABBV in Q4 2019 and has held it in 13 quarters since. The position peaked at $6.07M in Q2 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

tru Independence held 1,589 shares of AbbVie worth $346K as of Q1 2026.
tru Independence sold 17,848 AbbVie shares in Q1 2026, an estimated $3.96M.
AbbVie made up 0.17% of tru Independence's portfolio in Q1 2026, its #73 holding.
tru Independence first reported a position in AbbVie in Q4 2019 and has held it in 13 quarters since.
tru Independence's AbbVie position peaked at $6.07M in Q2 2024.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on tru Independence's 13F filing for Q1 2026, filed 22 Apr 2026.